– The US Food and Drug Administration (FDA) has been asked to provide a powerful congressional committee with records regarding two companies’ breast implants, and information about a criminal investigation of one maker for manufacturing violations.
In a letter to FDA Deputy Commissioner Lester Crawford sent on Thursday, Louisiana Republican Rep. Billy Tauzin and Pennsylvania Republican Rep. James Greenwood asked for records relating to studies conducted by Mentor Corp. and Inamed Corp., two makers of saline-filled breast implants. Reps. Tauzin and Greenwood respectively are chairs of the House Energy and Commerce Committee and its oversight subcommittee.
The lawmakers’ request follows an FDA advisory panel meeting that took place earlier this week, during which the companies reported that up to a quarter of women receiving breast implants for cosmetic reasons need replacement operations within five years. The reported numbers for women undergoing reconstructive surgery were even higher.
e-Med Tools
קצר קולע וממוקד
e-Med סמינרים
אי-מד תחקירים
Medscape Tools
Journal Club
מרכזי מידע ושירות
Facebook
מידע למפרסם
מאגר תרופות
מאגר אנשי המקצוע
אינדקס שימושי
חדשות משה"ב
eMed HealthClub
מחקרים קליניים
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!